Last Update 16 Aug 2023 03 Oct 2025

Welcome to RPPEO's Drug Availability Database, a one stop site for information on drug availability for Ontario Paramedicine.

...

The Drug Availability Database is maintained by the Regional Paramedic Program for Eastern Ontario (RPPEO) on a publicly accessible site, with data manually entered on a weekly basis, primarily from Health Canada's Drug Product Database, Drug Shortages Canada, and the Government of Canada's Recalls and Safety Alerts. Secondary sources include ad hoc updates on drug availability, expiry date extensions, recall notices, etc. from paramedic services, pharmaceutical suppliers, and manufacturers. We welcome drug availability information from users of the Drug Availability Database; please email information to RPPEO-Quality@toh.ca.

Using the Drug Availability Database

Drugs are listed in alphabetical order of active ingredient, then manufacturer and trade name. Included in the Drug (Active Ingredient) column is the ATC code, and the Equipment Standards (v3.7 01Feb2023) requirements.
The drug Status is current to the last modified date/time shown directly under the title of this page, according to the legend below. The last two columns, Notes and JIRA, are only completed if applicable; the former containing relevant information, while the later contains restricted-access organisationorganization-specific case management links.
Certain drugs are optional, used for research, expected soon, or not included in either the equipment standards or the ALS PCS, these are indicated in magenta text.
If the drug preparation used within your Paramedic Service is not included in the Drug Availability Database, please email the particulars to RPPEO-Quality@toh.ca and we will add these.
Drug presentations carried by paramedic services within the RPPEO region are indicated in the RPPEO column
For technical issues please email RPPEOBHITS@rppeo.ca

Drug Status Legend

Status	Meaning
Available	No Drug Shortage report and no Paramedic Services reporting supply issues
Available	No Drug Shortage reported and no Paramedic Services reporting supply issues, but there is information to consider
Supplier Issue	No Drug Shortage report, but Paramedic Services reporting supply issues
Anticipated Shortage	Anticipated Drug Shortage reported
Shortage	Drug Shortage reported
Discontinued (date)	Drug has been discontinued but supply is potentially still in use until date indicated. Will be removed from list after stated date.
(T3)	May be combined with Anticipated Shortage, Shortage, or Discontinuation. Represents the potential for highest impact on Canada's healthcare

Drug Availability Database

Drug (Active Ingredient)

Manufacturer

Trade Name

DIN

Presentation

Status

Notes

RPPEO

JIRA

Acetaminophen

N02BE01

All units
Min: 1920 mg
Std: 960 - 1000 mg/dose

Checked 13-Mar-2024

Apotex

Acetaminophen Tablets USP

02362244

500 mg tablet

Available

Y

Apotex

Acetaminophen Tablets USP

02362422

325 mg tablet

Available

Apotex

APO-Acetaminophen

00544981

325 mg tablet

AvailableCellchem PharmaceuticalsAcetaminophen Tablets Extra Strength

	Shortage	Estimated end 11-Nov-2025
Apotex	Apo-Acetaminophen caplets extra strength	02229977

02252813

500 mg tablet

AvailableCellchem PharmaceuticalsAcetaminophen Tablets Regular Strength02252805

Shortage	Estimated end 31-Oct-2025	Y
Apotex	Apo-Acetaminophen extra strength	00545007	500

325

mg tablet

Available

JAMP PharmaJAMP Acetaminophen 325

		Y
Apotex / CareRx	Apo-Acetaminophen caplets	02229873

01938088

325 mg tablet

Available

	Shortage	Estimated end 31-Oct-2025	Y
Cellchem Pharmaceuticals	Acetaminophen Tablets Extra Strength	02252813

JAMP PharmaJAMP Acetaminophen 50001939122

500 mg tablet

Available

JAMP Pharma


Cellchem Pharmaceuticals

JAMP

Acetaminophen

Blazon 50002355299

Tablets Regular Strength

02252805

325

500

mg tablet

ShortageDormant until 31-Dec-2023Laboratoire RivaAcetaminophene Blason Shield02362201

Available
JAMP Pharma	JAMP Acetaminophen 325	01938088	325

500

mg tablet

ShortageDormant, TBD

Available	https://recalls-rappels.canada.ca/en/alert-recall/jamp-acetaminophen-tablet-overweight-underweight-tablets?utm_source=gc-notify&utm_medium=email&utm_content=en&utm_campaign=hc-sc-rsa-22-23 Recall for lot numbers: EG22AMP013, EG22AMP014, EG22AMP015
JAMP Pharma	JAMP Acetaminophen 500	01939122	500 mg tablet	Available	https://recalls-rappels.canada.ca/en/alert-recall/jamp-acetaminophen-tablet-overweight-underweight-tablets?utm_source=gc-notify&utm_medium=email&utm_content=en&utm_campaign=hc-sc-rsa-22-23 Recall for lot numbers: EG22AMQ034, EG22AMQ035, EG22AMQ036, EG22AMQ042
JAMP Pharma	JAMP Acetaminophen Blazon 500	02355299	500 mg tablet	Shortage	Dormant until 31-Dec-2023
Laboratoire Riva	Acetaminophene Blason Shield	02362201	500 mg tablet	Shortage	Dormant, TBD
Laboratoire Riva	Acetaminophene caplet	02362228	500 mg tablet	Available		Y
Laboratoire Riva	Acetaminophene comprime tablet	02022222	500 mg tablet	Shortage	Dormant, TBD
Laboratoire Riva	Acetaminophene comprime tablet	02022214

Laboratoire RivaAcetaminophene comprime tablet02022222500 mg tabletShortageDormant, TBDLaboratoire RivaAcetaminophene comprime tablet02022214325 mg tabletAvailableLaboratories TrianonAcetaminophen Tab USP00789798500 mg tabletAvailableLaboratories TrianonAcetaminophen Tab USP00789801325 mg tabletAvailableMcNeil Consumer HealthcareTylenol extra strength00559407500 mg tabletAvailableMcNeil Consumer HealthcareTylenol rapid release00863270500 mg tabletAvailableMcNeil Consumer HealthcareTylenol regular strength00559393325 mg tabletAvailableTevaNovo-Gesic00389218

325 mg tablet

Available

TevaNovo-Gesic Forte


Laboratories Trianon	Acetaminophen Tab USP	00789798

00482323

500 mg tablet

Available

Vita Health Products


Laboratories Trianon	Acetaminophen

Tablets

Tab USP

00605751

00789801

325 mg tablet

Available

Vita Health ProductsExtra strength acetaminophen


McNeil Consumer Healthcare	Tylenol extra strength	00559407

02285797

500 mg tablet

Available

Vita Health ProductsExtra strength acetaminophen tablets


McNeil Consumer Healthcare	Tylenol rapid release	00863270

00605778

500 mg tablet

Available

Zee MedicalPainaid Free Acetaminophen Tablets02144514


McNeil Consumer Healthcare	Tylenol regular strength	00559393	325

500

mg tablet

Available

Adenosine


Teva

C01EB10

ACP units
Min: 36 mg
Std: 6 and/or 12 mg preparations

Fresenius KabiAdenosine Injection022676593 mg/ml in 2 ml vialAvailableFresenius KabiAdenosine Injection024574746 mg in 2 ml prefilled syringeAvailableFresenius KabiAdenosine Injection0245748212 mg in 4 ml prefilled syringeAvailable

Amiodarone

C01BD01

ACP units if not carrying lidocaine injection
Min: 600 mg
Std: n/a

Fresenius KabiAmiodarone hydrochloride injection0224524850 mg/ml in 3 ml vialAvailableJAMP PharmaAmiodarone hydrochloride injection0242322750 mg/ml in 3 ml vialShortageEstimated end date 31-Dec-2023SandozAmiodarone hydrochloride injection0224232550 mg/ml in 3 ml vialAvailable50 mg/ml x 9 ml vialAvailable

Antibiotic eye drops

Chem-Ex Auxiliary

Antibiotic ointment

Special Event Auxiliary

ASA (Acetylsalicylic acid)

B01AC06
N02BA01

All units
Min: 6 tablets
Std: 80 or 81 mg tablets

Altamed PharmaASA0249711580 mg chewable tabletAvailableBayerAspirin 81 mg quick chews0228997081 mg chewable tabletAvailableBiomed PharmaBIO-ASA0251568780 mg chewable tabletAvailableJAMP PharmaJAMP-ASA Chew0226913980 mg chewable tabletAvailableLaboratoire RivaRIVASA Croquable - Tab0220235280 mg chewable tabletAvailableMantra PharmaM-ASA Croquable0242995080 mg chewable tabletAvailableOdan LaboratoriesASATAB Chewable Tablets0228016780 mg chewable tabletAvailablePendopharmEntrophen Chewable0224397481 mg chewable tabletAvailablePharmascienceASA daily low dose0239479081 mg chewable tabletAvailablePharmascienceASAPHEN0200901380 mg chewable tabletAvailablePro DocPRO-AAS (Croquable)0231151880 mg chewable tabletAvailable

Atropine

A03BA01

ACP units
Min: 2 mg
Std: n/a

Labortoire AguettantAtropine Sulfate Injection024262771 mg in 5 ml prefilled syringeAvailablePfizerAtropine Sulfate Injection USP Abboject003281541 mg in 10 ml prefilled syringeAvailableAtropine Sulfate Injection USP LifeShield1 mg in 10 ml prefilled syringeAvailable

Buprenorphine/Naloxone

N07BC51

Optional

IndiviorSuboxone022957098 mg/2 mg SL tabletAvailableIndiviorSuboxone025023488 mg/2 mg soluble filmAvailablePharmasciencePMS-Buprenorphine-Naloxone 024248788 mg/2 mg SL tabletAvailableTevaTeva-Buprenorphine/Naloxone 024539168 mg/2 mg SL tabletAvailable

Calcium Gluconate

B05BB01

ACP units
Min: 4 g
Std: 10% (1g/10 ml)

Fresenius KabiCalcium Gluconate USP 10%02141019100 mg/ml in 10 ml vialAvailable

Dexamethasone

H02AB02

All units
Min: 16 mg
Std: n/a

Omega LaboratoriesDexamethasone Omega Unidose0238774310 mg/ml x 1 ml vialAvailableOmega LaboratoriesDexamethasone-Omega022042664 mg/ml x 5 ml vialAvailableOmega LaboratoriesDexamethasone-Omega0220427410 mg/ml x 1 ml vialShortage

Estimated end date 13-Oct-2023

Some product still available with CPDN

SandozDexamethasone Sodium Phosphate Inj USP006642274 mg/ml x 5 ml vialAvailableSandozDexamethasone Sodium Phosphate Inj USP0087458210 mg/ml x 1 mlAvailable

Dextrose

B05BA03

ACP/PCP (AIV) units
Min: 4
Std: 10% (10 g/100 ml) OR 50% (25 g/50 ml)

Alternative names:

10% = D10 or 100 mg/ml
50% = D50 or 500 mg/ml

B Braun10% Dextrose Injection USP0192442710% in 500 ml IV bagAvailableBaxter10% Dextrose Injection, USP0006036410% in 500 ml IV bagAvailableICU MedicalDextrose Injection USP0003797450% in 50 mlAvailableOmega LaboratoriesDextrose Injection0251713250% in 50 ml vialShortage

Estimated end date 06-Oct-2023

On allocation and is available to contract customers at 50% allocation rate.

PfizerDextrose Injection USP0246851450% in 50 ml vialShortageEstimated end date, TBDANSYR syringe50% in 50 ml prefilled syringeShortage

Estimated end date, TBD

On allocation

LifeShield syringe50% in 50 ml prefilled syringeShortageEstimated end date, TBD

Diazepam

N05BA01

Chem-Ex Auxiliary
Not in equipment standards

SandozDiazepam injection USP003997285 mg/ml in 2 ml ampoulesAvailable

DimenhyDRINATE

R06AA11

All units
Min: 100
Std: n/a

Church & DwightGravol IM0001357950 mg/ml in ampouleAvailableHikmaDimenhyDRINATE Injection USP0242895450 mg/ml x 1 ml ampouleAvailableSandozDimenhyDRINATE Injection USP0039253750 mg/ml x 1 ml ampouleAvailable

DiphenhydrAMINE
(injection)

R06AA02

All units
Min: 100 mg
Std: n/a

Fresenius KabiDiphenhydrAMINE Hydrochloride Injection0236956750 mg/ml in 1 ml vialAvailableOmega LaboratoriesDiphenist0221933650 mg/ml in 1 ml vialShortageSandozDiphenhydrAMINE Hydrochloride Injection USP0059661250 mg/ml in 1 ml Shortage

DiphenhydrAMINE
(oral)

R06AA02

Special Event Auxiliary

JAMP PharmaJAMP DiphenhydrAMINE02257548 25 mg tabletAvailableJAMP PharmaJAMP DiphenhydrAMINE0225755650 mg tabletAvailableLaboratoire LalcoDormiphen extra-forte comprime02237789 50 mg tabletAvailableMcNeil Consumer HealthcareBenadryl allergy02017849 25 mg tabletAvailableMcNeil Consumer HealthcareExtra strength Benadryl allergy02470144 50 mg tabletAvailablePaladin LabsUnisom01946986 50 mg tabletAvailableTanta PharmaceuticalsAllergy formula extra strength02532484 50 mg tabletAvailableTevaAllernix02097583 25 mg tabletAvailableTevaAllernix extra strength02097575 50 mg tabletAvailableVita Health ProductsAllergy formula02229492 25 mg tabletAvailableVita Health ProductsAllergy formula extra strength02490943 50 mg tabletAvailable

Dopamine

C01CA04

ACP units
Min: 2 bags
Std: 200 mg/250 ml OR
~~200 mg/5 ml~~

BaxterDopamine HCL 0.8mg/ml Dextrose 5% Inj USP007618500.8 mg/ml in 250 ml solutionAvailable

CMP-32879

EPINEPHrine 1:1,000 (1 mg/ml)

C01CA24

All units
Min: 10 mg
Std: n/a

HikmaEPINEPHrine Injection USP024358101 mg/ml in 1 ml ampouleAnticipated ShortagePfizerEPINEPHrine Injection USP007218911 mg/ml in 1 ml ampouleAvailableSearchlight PharmaAdrenalin001553571 mg/ml in 1 ml ampouleAvailable1 mg/ml in 30 ml vialAvailable

EPINEPHrine 1:10,000 (0.1 mg/ml)

C01CA24

ACP units
Min: 10 mg
Std: n/a

Laboratoire AguettantEPINEPHrine Injection 025211481 mg in 10 ml prefilled syringeAvailablePfizerEPINEPHrine Injection USP, LifeShield007108141 mg in 10 ml prefilled syringeAvailable

Fentanyl

N01AH01
N02AB03

Optional
Min: 400 mcg
Std: n/a

Fresenius KabiFentanyl Citrate Injection, USP0250155450 mcg/ml in 2 ml vialAvailableHikmaFentanyl Citrate Injection USP0238540650 mcg/ml in 2 ml vialAvailableJAMP PharmaFentanyl Citrate Injection0250696350 mcg/ml in 2 ml vialAvailableSandozFentanyl Citrate Injection USP0224043450 mcg/ml in 2 ml vialAvailableSandozFentanyl Citrate Injection USP0238412450 mcg/ml in 2 ml vialAvailableSterimaxFentanyl Injection BP0249614350 mcg/ml in 2 ml ampouleAvailable

Glucagon

H04AA01

All units
Min: 2 mg
Std: n/a

Eli Lilly
Expected drug
BAQSIMI024924153 mg powder in nasal dosing device

Available

CMP-34086

Eli LillyGlucagon022432971 mg as powder for reconstitution

Discontinued (T3)
05 Oct 2023

CMP-34086

Novo NordiskGlucagen023336191 mg as powder for reconstitution

Discontinued
01 Feb 2024

CMP-34086

Novo NordiskGlucagen Hypokit023336271 mg as powder for reconstitution

Discontinued (T3)
01 Feb 2024

CMP-34086

Glucose (oral)

All units
Min: 2
Std: 15 g/dose as paste, tables, or other formulation

Not considered a drug by Health Canada

Glycopyrrolate

A03AB02

Palliative
Not listed in Equipment Standards

JAMP PharmaGlycopyrrolate Injection USP025137490.2 mg/ml in 2 ml vialAvailableOmega LaboratoriesGlycopyrrolate injection023828570.2 mg/ml in 1 ml vialAvailable0.2 mg/ml in 2 ml vialAvailableSandozGlycopyrrolate Injection USP020395080.2 mg/ml in 1 ml vialAvailable0.2 mg/ml in 2 ml vialAvailableSterimaxGlycopyrrolate Injection USP024738790.2 mg/ml in 1 ml vialShortageSterimaxGlycopyrrolate Injection USP024738950.2 mg/ml in 2 ml vialAvailable

Haloperidol

N05AD01

Palliative
Not listed in Equipment Standards

Fresenius KabiHaloperidol injection USP024064115 mg/ml in 1 ml vialAvailableOmega LaboratoriesHaloperidol injection023660105 mg/ml in 1 ml vialAvailableSandozHaloperidol injection USP008086525 mg/ml in 1 ml ampouleAvailable

HYDROmorphone

N02AA03

Palliative
Not listed in Equipment Standards

Fresenius KabiHYDROmorphone Hydrochloride Injection, USP0249168010 mg/ml in 1 ml vialAvailableFresenius KabiHYDROmorphone Hydrochloride Injection, USP024916992 mg/ml in 1 ml vialAvailableJAMP PharmaHYDROmorphone Hydrochloride Injection USP025296452 mg/ml in 1 ml vialAvailableSandozHYDROmorphone HP 10 0214592810 mg/ml in 1 ml vialAvailableSandozHYDROmorphone Hydrochloride Injection USP021459012 mg/ml in 1 ml vialAvailableSterimaxHYDROmorphone Hydrochloride Injection HP 100246061010 mg/ml in 1 ml vialAvailableSterimaxHYDROmorphone Hydrochloride Injection USP024606022 mg/ml in 1 ml vialAvailable

Hydroxocobalamin

V03AB33

Chem Ex
Sodium Thiosulfate 25% is appropriate substitute
Not in equipment standards

Serb SACyanokit023753705 g powder for infusion in glass vialAvailable

Ibuprofen

M01AE01

All units
Min: 800 mg
Std: 400 mg/dose

ApotexApo-Ibuprofen00441643200 mg tabletAvailableApotexApo-Ibuprofen00506052400 mg tabletAvailableApotexApo-Ibuprofen02439689200 mg tabletAvailableGlaxoSmithKlineAdvil tablets01933558200 mg tabletAvailableJAMP PharmaIbuprofen02257912200 mg tabletAvailableJAMP PharmaIbuprofen02317338400 mg tabletAvailableMcNeil Consumer HealthcareMotrin02186934200 mg tabletAvailableMcNeil Consumer HealthcareMotrin02242658400 mg tabletAvailablePharmascienceExtra Strength Ibuprofen02314770400 mg tabletAvailablePharmascienceIbuprofen Tablets02314754200 mg tabletAvailableVita Health ProductsIbuprofen Tablets02272849200 mg tabletAvailableVita Health ProductsIbuprofen Tablets02368072200 mg tabletAvailable

Ketamine

N01AX03

ACP units
Min: 1000 mg
Std: n/a

SandozKetamine Hydrochloride USP0224679650 mg/ml in 10 ml vialAvailable50 mg/ml in 2 ml vialAvailableSearchlight PharmaKetalar0022440550 mg/ml in 10 ml vialAvailable

Ketorolac

M01AB15

All units
Min: 2 vials/amps
Std: 10 - 15 mg/dose

Atnahs PharmaTORADOL IM0216264410 mg/ml in 1 ml ampouleAvailableFresenius KabiKetorolac Tromethamine Injection, USP0224494730 mg/ml in 1 ml vialAvailableJuno PharmaceuticalsKetorolac Tromethamine Injection, USP0244337630 mg/ml in 1 ml vialAvailablePfizerKetorolac Tromethamine Injection, USP0239058230 mg/ml in 1 ml vialAnticipated ShortageSandozKetorolac Tromethamine Injection, USP0223994430 mg/ml in 1 ml vialAvailable

Lidocaine injection

C01BB01

ACP units if not carrying amiodarone
Min: 600 mg
Std: n/a

Aspen PharmacareXylocard00001937100 mg in 5 ml prefilled syringeAvailableLaboratoire AguettantLidocaine Hydrochloride injection02522268100 mg in 5 ml prefilled syringeAvailablePfizerLidocaine Hydrochloride injection USP: Abboject00436208100 mg in 5 ml prefilled syringeAvailableLidocaine Hydrochloride injection USP: Ansyr100 mg in 5 ml prefilled syringeShortageProduct on allocationLidocaine Hydrochloride injection USP: LifeShield100 mg in 5 ml prefilled syringeShortage

Lidocaine spray

N01BB02

ACP units
Min: 2
Std: 10 mg/spray

Aspen PharmacareXylocaine Spray0200376710 mg/metered dose sprayAvailableOdan LaboratoriesLidoan endotracheal non-aerosol spray02231147 10 mg/metered dose sprayAvailable

Methoxyflurane 99.9%

Research Project
Not in equipment standards

Endo VenturesPenthrox24747273 ml bottle and inhalerShortagePaladin Labs is taking over distribution

Midazolam

N05CD08

ACP units
Min: 20 mg
Std: n/a

Fresenius KabiMidazolam injection022429055 mg/ml x 2 ml vialAvailablePfizerMidazolam injection USP023823505 mg/ml x 2 ml vialAvailablePfizerMidazolam injection USP023823855 mg/ml x 2 ml vialAvailableSandozMidazolam injection022402865 mg/ml x 2 ml vialAvailable

Morphine

N02AA01

ACP units
Min: 40 mg
Std: n/a

Fresenius KabiMorphine Sulfate injection, USP0248274610 mg/ml in 1 ml vialAvailableJAMP PharmaMorphine Sulfate injection0250072810 mg/ml in 1 ml ampouleAvailableJAMP PharmaMorphine Sulfate injection0250073615 mg/ml in 1 ml ampouleAvailableSandozMorphine Sulfate injection USP0238299710 mg/ml in 1 ml ampouleAvailableSandozMorphine Sulfate injection USP0039256115 mg/ml in 1 ml ampouleAvailableSandozMorphine Sulfate injection BP0039258810 mg/ml in 1 ml ampouleAvailableSterimaxMorphine Sulfate injection BP0247498015 mg/ml in 1 ml ampouleAvailable

Naloxone

V03AB15

All units
Min: 12 mg
Std: n/a

HikmaNaloxone hydrochloride injection USP023824820.4 mg/ml in 1 ml ampouleAvailableHikmaNaloxone injectable024585780.4 mg/ml in 1 ml ampouleAvailableOmega LaboratoriesInjectable naloxone hydrochloride024559350.4 mg/ml in 1 ml vialAvailableSandozNaloxone HCL Injection021487060.4 mg/ml in 1 ml ampouleAvailableSandozNaloxone HCL Injection021487141 mg/ml in 2 ml vialAvailableSandozS.O.S. Naloxone hydrochloride injection024532580.4 mg/ml in 1 ml ampouleAvailable

Nitroglycerin

C01DA02

All units
Min: 2 canisters or bottles
Std: 0.4 mg/dose, aerosol OR 0.3 or 0.4 mg/dose tablets

BGP PharmaNitrostat000376130.3 mg SL tabletAnticipated Shortage

CMP-32011

Mylan PharmaceuticalsMylan-Nitro Sublingual Spray022435880.4 mg/metered dose sprayShortage (T3)Expiry date extensionCMP-32011SandozRho-Nitro Pumpspray022389980.4 mg/metered dose sprayAvailableCMP-32011Sanofi-AventisNitrolingual Pumpspray022314410.4 mg/metered dose sprayShortage (T3)CMP-32011

Ondansetron injection

A04AA01

Palliative

Auro PharmaAuro-ondansetron injection024915242 mg/ml in 2 ml vialAvailableAuro PharmaAuro-ondansetron injection024915322 mg/ml in 2 ml vialAvailableAuro PharmaOndansetron Injection BP024614202 mg/ml in 2 ml ampouleAvailableMarcan PharmaceuticalsOndansetron Injection USP025039052 mg/ml in 2 ml vialAvailableSandozOndansetron Hydrochloride Dihydrate Injection022744182 mg/ml in 2 ml ampouleAvailableSandozOndansetron Injection USP022794282 mg/ml in 2 ml vialAvailableSterimaxOndansetron Injection USP024645782 mg/ml in 2 ml vialAvailable

Ondansetron oral

A04AA01

All units
Min: 8 mg
Std: n/a

Accel PharmaAccel-Ondansetron024789274 mg tabletAvailableApotexApo-ondansetron022881844 mg tabletShortage10 BLS shortage, 30 Btl availableAthena PharamaceutiquesAthena-ondansetron ODT024446744 mg orally disintegrating tabletAvailableAuro PharmaAuro-ondansetron ODT025112824 mg orally disintegrating tabletShortageJAMP PharmaJAMP-Ondansetron023136854 mg tabletAvailableJAMP PharmaOndansetron ODT025192324 mg orally disintegrating tabletAvailableMarcan PharmaceuticalsMar-Ondansetron023717314 mg tabletAvailableMarcan PharmaceuticalsMar-Ondansetron ODT025149664 mg orally disintegrating tabletAvailableMint PharmaceuticalsMint-Ondansetron023052594 mg tabletAvailableMint PharmaceuticalsMint-Ondansetron ODT024873304 mg orally disintegrating tabletAvailableMylan PharmaceuticalsMylan-Ondansetron022978684 mg tabletAvailableNatco PharmaNat-Ondansetron024178394 mg tabletAvailablePharmasciencePMS-Ondansetron022581884 mg tabletAvailablePharmasciencePMS-Ondansetron ODT025194454 mg orally disintegrating tabletAvailableSandozOndansetron ODT024817234 mg orally disintegrating tabletAvailableSandozSandoz-Ondansetron022743104 mg tabletAvailableSandozZofran ODT022393724 mg orally disintegrating tabletDiscontinued
31 Jan 2025Sanis HealthOndansetron024214024 mg tabletAvailableTakedaOndissolve023899834 mg oral soluble filmAvailableTevaTeva-Ondansetron022963494 mg tabletAvailable

Oxytocin

H01BB02

All units
Min: 20 units (2 doses)
Std: 10 units/ml

Fresenius KabiOxytocin Injection USP0213956110 units/ml in 1 ml vialAvailable

CMP-33205

PfizerOxytocin Injection USP0049739810 units/ml in 1 ml ampouleShortage

CMP-33205

Pralidoxime

V03AB13

Chem Ex
Not in equipment standards

Not marketed in Canada

Salbutamol inhalation solution

R03AC02

All units
Min: 25 mg
Std: n/a

PharmasciencePMS-Salbutamol022082292.5 mg in 2.5 ml nebuleAvailablePharmasciencePMS-Salbutamol022082375 mg in 2.5 ml nebuleAvailableTevaTeva-Salbutamol Sterinebs019269342.5 mg in 2.5 ml nebuleAvailableTevaTeva-Salbutamol Sterinebs021733605 mg in 2.5 ml nebuleAvailable

Salbutamol MDI

R03AC02

All units
Min: 2 canisters
Std: 100 mcg/puff, aerosol

ApotexApo-Salbutamol HFA02245669100 mcg/metered dose MDIAnticipated ShortageBausch HealthAiromir02232570100 mcg/metered dose MDIAvailableGlaxoSmithKlineVentolin HFA02241497100 mcg/metered dose MDIAvailableSanis HealthSalbutamol HFA02419858100 mcg/metered dose MDIAvailableTevaTeva-Salbutamol HFA02326450100 mcg/metered dose MDIAvailable

Sodium Bicarbonate

B05XA02

ACP units
Min: 2
Std: 50 mEq/50 ml
(50 ml of 84 mg/ml)

Fresenius KabiSodium Bicarbonate Injection, USP0248663650 mEq in 50 ml vialAvailableJAMP PharmaSodium Bicarbonate Injection USP0251622550 mEq in 50 ml vialAvailableOmega LaboratoriesSodium Bicarbonate Injection USP0246758550 mEq in 50 ml vialAvailablePfizerSodium Bicarbonate Injection USP, ABBOJECT Syringe0026199850 mEq in 50 ml prefilled syringeAvailablePfizerSodium Bicarbonate Injection USP, fliptop Vial50 mEq in 50 ml vialShortagePfizerSodium Bicarbonate Injection USP, LifeShield Syringe50 mEq in 50 ml prefilled syringeShortage

Novo-Gesic	00389218	325 mg tablet	Available
Teva	Novo-Gesic Forte	00482323	500 mg tablet	Available
Vita Health Products	Acetaminophen Tablets	00605751	325 mg tablet	Available
Vita Health Products	Extra strength acetaminophen	02285797	500 mg tablet	Available
Vita Health Products	Extra strength acetaminophen tablets	00605778	500 mg tablet	Available
Zee Medical	Painaid Free Acetaminophen Tablets	02144514	500 mg tablet	Available
Adenosine C01EB10 ACP units Min: 36 mg Std: 6 and/or 12 mg preparations Checked 13-Mar-2024	Fresenius Kabi	Adenosine Injection	02267659	3 mg/ml in 2 ml vial	Available		Y
	Fresenius Kabi	Adenosine Injection	02457474	6 mg in 2 ml prefilled syringe	Available		Y
	Fresenius Kabi	Adenosine Injection	02457482	12 mg in 4 ml prefilled syringe	Shortage	Estimated end 15-May-2024 Adenosine Injection 3 mg/mL Prefilled syringe 2 mL will be available for substitution.	Y
Amiodarone C01BD01 ACP units if not carrying lidocaine injection Min: 600 mg Std: n/a Checked 13-Mar-2024	Fresenius Kabi	Amiodarone hydrochloride injection	02245248	50 mg/ml in 3 ml vial	Anticipated Shortage	Estimated end 24-Aug-2024	Y
	JAMP Pharma	Amiodarone hydrochloride injection	02423227	50 mg/ml in 3 ml vial	Shortage	Estimated end 12-Mar-2024
	Sandoz	Amiodarone hydrochloride injection	02242325	50 mg/ml in 3 ml vial	Available		Y
	Sandoz	Amiodarone hydrochloride injection	02242325	50 mg/ml x 9 ml vial	Available
Antibiotic eye drops S01HA03 Chem-Ex Auxiliary Checked 13-Mar-2024	Bausch & Lomb	Minims Tetracaine Hydrochloride	02148528	0.5% in 5 ml	Available		Y
Antibiotic ointment D06AX30 Special Event Auxiliary Checked 13-Mar-2024	Johnson & Johnson	Polysporin Antibiotic Cream	02230844	15 g or 30 g tube	Available
	Johnson & Johnson	Polysporin Antibiotic Ointment	02237227	15 g or 30 g tube	Available		Y
	Johnson & Johnson	Polysporin Complete	02240568	15 g or 30 g tube	Available
	Johnson & Johnson	Polysporin Triple Antibiotic Ointment	02237226	15 g or 30 g tube	Available
ASA (Acetylsalicylic acid) B01AC06 N02BA01 All units Min: 6 tablets Std: 80 or 81 mg tablets Checked 13-Mar-2024	Altamed Pharma	ASA	02497115	80 mg chewable tablet	Available
	Bayer	Aspirin 81 mg quick chews	02289970	81 mg chewable tablet	Available
	Biomed Pharma	BIO-ASA	02515687	80 mg chewable tablet	Shortage	Dormant, TBD	Y
	CareRx	ASA chew	unknown	80 mg			Y
	JAMP Pharma	JAMP-ASA Chew	02269139	80 mg chewable tablet	Available		Y
	Laboratoire Riva	RIVASA Croquable - Tab	02202352	80 mg chewable tablet	Available
	Mantra Pharma	M-ASA Croquable	02429950	80 mg chewable tablet	Available
	Odan Laboratories	ASATAB Chewable Tablets	02280167	80 mg chewable tablet	Available		Y
	Pendopharm	Entrophen Chewable	02243974	81 mg chewable tablet	Available
	Pharmascience	ASA daily low dose	02394790	81 mg chewable tablet	Available
	Pharmascience	ASAPHEN	02009013	80 mg chewable tablet	Available	Drug Shortage Report for ASAPHEN	Y
	Pro Doc	PRO-AAS (Croquable)	02311518	80 mg chewable tablet	Available	Drug Shortage Report for PRO-AAS - 80 (CROQUABLE)
Atropine A03BA01 ACP units Min: 2 mg Std: n/a Checked 13-Mar-2024	Hikma / Teligent	Atropine Injection BP	02432188	0.4 mg/ml in 1 ml ampoule	Available		Y
	Hikma / Teligent	Atropine Injection BP	02432196	0.6 mg/ml in 1 ml ampoule	Available		Y
	Labortoire Aguettant	Atropine Sulfate Injection	02426277	1 mg in 5 ml prefilled syringe	Available		Y
	Pfizer	Atropine Sulfate Injection USP Abboject LifeShield	00328154	1 mg in 10 ml prefilled syringe	Discontinued (18-Aug-2025)	Drug Shortage Report for ATROPINE SULFATE INJECTION USP Estimated discontinuation 18-Aug-2025 Recall notice: 20 Sep 2023 ATROPINE SULFATE INJECTION USP: Affected lot may contain the presence of glass particulate.	Y
	Sandoz	Atropine Sulfate Injection USP	00392693	0.6 mg/ml in 1 ml ampoule	Available		Y
	Sandoz	Atropine Sulfate Injection USP	00392782	0.6 mg/ml in 1 ml ampoule	Available
Buprenorphine/Naloxone N07BC51 Optional	Indivior	Suboxone	02295709	8 mg/2 mg SL tablet	Available
	Indivior	Suboxone	02502348	8 mg/2 mg soluble film	Available
	Pharmascience	PMS-Buprenorphine-Naloxone	02424878	8 mg/2 mg SL tablet	Available
	Teva	Teva-Buprenorphine/Naloxone	02453916	8 mg/2 mg SL tablet	Shortage	Estimated end 31-Jan-2026
Calcium Gluconate B05BB01 ACP units Min: 4 g Std: 10% (1g/10 ml)	Fresenius Kabi	Calcium Gluconate USP 10%	02141019	100 mg/ml in 10 ml vial	Available		Y
Dexamethasone H02AB02 All units Min: 16 mg Std: n/a	Omega Laboratories	Dexamethasone Omega Unidose	02387743	10 mg/ml x 1 ml vial	Available		Y
	Omega Laboratories	Dexamethasone-Omega	02204266	4 mg/ml x 5 ml vial	Shortage	Estimated end 15-Nov-2024
	Omega Laboratories	Dexamethasone-Omega	02204274	10 mg/ml x 1 ml vial	Anticipated Shortage
	Sandoz	Dexamethasone Sodium Phosphate Inj USP	00664227	4 mg/ml x 5 ml vial	Available		Y
	Sandoz	Dexamethasone Sodium Phosphate Inj USP	00874582	10 mg/ml x 1 ml	Available		Y
Dextrose B05BA03 ACP/PCP (AIV) units Min: 4 Std: 10% (10 g/100 ml) OR 50% (25 g/50 ml) Alternative names: 10% = D10 or 100 mg/ml 50% = D50 or 500 mg/ml	B Braun	10% Dextrose Injection USP	01924427	(100 mg/ml) 10% in 500 ml IV bag	Available		Y
	B Braun	10% Dextrose Injection USP	01924427	(100 mg/ml) 10% in 250 ml IV bag	Available		Y
	Baxter	10% Dextrose Injection, USP	00060364	(100 mg/ml) 10% in 500 ml IV bag	Available
	Omega Laboratories	Dextrose Injection	02517132	(500 mg/ml) 50% in 50 ml vial	Shortage	Estimated end, 31-Oct-2025 Some product available at CPDN. We have released a batch, but the product is still subject to allocation.
	Pfizer	Dextrose Injection USP	02468514	(500 mg/ml) 50% in 50 ml vial	Shortage	Estimated end, TBD Affected lot number: LH2756 & LY3589 EPINEPHRINE, SODIUM BICARBONATE & DEXTROSE USP INJECTIONS : Possible microbiological contamination. - Canada.ca
		ANSYR syringe		(500 mg/ml) 50% in 50 ml prefilled syringe	Available	Lifeshield syringe discontinued, ANSYR syringe remains available
		LifeShield syringe		(500 mg/ml) 50% in 50 ml prefilled syringe	Discontinued (18-Aug-2025)	ANSYR syringe remains available
Diazepam N05BA01 Chem-Ex Auxiliary Not in equipment standards	Sandoz	Diazepam injection USP	00399728	5 mg/ml in 2 ml ampoules	Available
DimenhyDRINATE R06AA11 All units Min: 100 Std: n/a	Church & Dwight	Gravol IM	00013579	50 mg/ml in ampoule	Shortage	Estimated end unknown	Y
	Hikma	DimenhyDRINATE Injection USP	02428954	50 mg/ml x 1 ml ampoule	Available		Y
	Sandoz	DimenhyDRINATE Injection USP	00392537	50 mg/ml x 1 ml ampoule	Available		Y
DiphenhydrAMINE (injection) R06AA02 All units Min: 100 mg Std: n/a	Fresenius Kabi	DiphenhydrAMINE Hydrochloride Injection	02369567	50 mg/ml in 1 ml vial	Available		Y
	Omega Laboratories	Diphenist	02219336	50 mg/ml in 1 ml vial	Avoided Shortage	Estimated end 30-Sept-2025 They are currently collaborating with Health Canada's Drug Shortages Unit to mitigate any market impact.	Y
	Sandoz	DiphenhydrAMINE Hydrochloride Injection USP	00596612	50 mg/ml in 1 ml	Available		Y
DiphenhydrAMINE (oral) R06AA02 Special Event Auxiliary	JAMP Pharma	JAMP DiphenhydrAMINE	02257548	25 mg tablet	Available
	JAMP Pharma	JAMP DiphenhydrAMINE	02257556	50 mg tablet	Available
	Laboratoire Lalco	Dormiphen extra-forte comprime	02237789	50 mg tablet	Available
	McNeil Consumer Healthcare	Extra strength Benadryl allergy	02470144	50 mg tablet	Available
	McNeil / Johnson & Johnson	Benadryl allergy	02017849	25 mg tablet	Available		Y
	Paladin Labs	Unisom	01946986	50 mg tablet	Available
	Tanta Pharmaceuticals	Allergy formula extra strength	02532484	50 mg tablet	Available
	Teva	Allernix	02097583	25 mg tablet	Discontinued	Discontinued 2019-07-31 due to business reasons
	Teva	Allernix extra strength	02097575	50 mg tablet	Discontinued	Discontinued 2019-07-31 due to business reasons
	Vita Health Products	Allergy formula	02229492	25 mg tablet	Available
	Vita Health Products	Allergy formula extra strength	02490943	50 mg tablet	Available
Dopamine C01CA04 ACP units Min: 2 bags Std: 200 mg/250 ml OR ~~200 mg/5 ml~~	Baxter	Dopamine HCL 0.8mg/ml Dextrose 5% Inj USP	00761850	0.8 mg/ml in 250 ml solution	Available		Y	CMP-32879
EPINEPHrine 1:1,000 (1 mg/ml) C01CA24 All units Min: 10 mg Std: n/a	Hikma	EPINEPHrine Injection USP	02435810	1 mg/ml in 1 ml ampoule	Available		Y
	Pfizer	EPINEPHrine Injection USP	00721891	1 mg/ml in 1 ml ampoule	Available	Drug Shortage Report for EPINEPHRINE INJECTION USP	Y
	Searchlight Pharma	Adrenalin	00155357	1 mg/ml in 1 ml ampoule	Available
	Searchlight Pharma	Adrenalin	00155357	1 mg/ml in 30 ml vial	Available		Y
EPINEPHrine 1:10,000 (0.1 mg/ml) C01CA24 ACP units Min: 10 mg Std: n/a	Laboratoire Aguettant	EPINEPHrine Injection	02521148	1 mg in 10 ml prefilled syringe	Shortage	Estimated end Sep-09-2024
	Pfizer	EPINEPHrine Injection USP, LifeShield	00710814	1 mg in 10 ml prefilled syringe	Discontinued (18-Aug-2025)	Drug Shortage Report for EPINEPHRINE INJECTION USP Affected lot number: LR4585, LN2814, LN2813 & LX1239 EPINEPHRINE, SODIUM BICARBONATE & DEXTROSE USP INJECTIONS : Possible microbiological contamination. - Canada.ca	Y	CMP-35519
Fentanyl N01AH01 N02AB03 Optional Min: 400 mcg Std: n/a	Fresenius Kabi	Fentanyl Citrate Injection, USP	02501554	50 mcg/ml in 2 ml vial	Available
	Hikma	Fentanyl Citrate Injection USP	02385406	50 mcg/ml in 2 ml vial	Shortage	Estimated end, TBD	Y
	JAMP Pharma	Fentanyl Citrate Injection	02506963	50 mcg/ml in 2 ml vial	Available
	Sandoz	Fentanyl Citrate Injection USP	02240434	50 mcg/ml in 2 ml vial	Available		Y
	Sandoz	Fentanyl Citrate Injection USP	02384124	50 mcg/ml in 2 ml vial	Available		Y
	Sterimax	Fentanyl Injection BP	02496143	50 mcg/ml in 2 ml ampoule	Shortage	Estimated end 18-Aug-2025
Glucagon H04AA01 All units Min: 2 mg Std: n/a	Amphastar Pharmaceuticals	Glucagon Injection	US FDA 0548-5850-00	1 mg as powder for reconstitution	Unknown	US product that may be imported until 31 Dec 2024		CMP-34086
	Amphastar Pharmaceuticals	BAQSIMI	02492415	3 mg powder in nasal dosing device	Available	Change in packaging site		CMP-34086
	Eli Lilly	Glucagon	02243297	1 mg as powder for reconstitution	Discontinued (T3)	Last supplies have been delivered.	Y	CMP-34086
	Novo Nordisk	Glucagen	02333619	1 mg as powder for reconstitution	Discontinued	Remaining supply 29-Feb-2024		CMP-34086
	Novo Nordisk	Glucagen Hypokit	02333627	1 mg as powder for reconstitution	Discontinued	Remaining supply 29-Feb-2024 See Report ID: 198052. The product will be discontinued with a stock depletion date of February 29, 2024.	Y	CMP-34086
Glucose (oral) All units Min: 2 Std: 15 g/dose as paste, tables, or other formulation	Not considered a drug by Health Canada
Glycopyrrolate A03AB02 Palliative Not listed in Equipment Standards	JAMP Pharma	Glycopyrrolate Injection USP	02513749	0.2 mg/ml in 2 ml vial	Available
	Omega Laboratories	Glycopyrrolate injection	02382857	0.2 mg/ml in 1 ml vial	Shortage	Estimated end 31-Oct-2025
	Omega Laboratories	Glycopyrrolate injection	02382857	0.2 mg/ml in 2 ml vial	Available		Y
	Sandoz	Glycopyrrolate Injection USP	02039508	0.2 mg/ml in 1 ml vial	Available
	Sandoz	Glycopyrrolate Injection USP	02039508	0.2 mg/ml in 2 ml vial	Available		Y
	Sterimax	Glycopyrrolate Injection USP	02473879	0.2 mg/ml in 1 ml vial	Shortage	Estimated end 31-Oct-2025
	Sterimax	Glycopyrrolate Injection USP	02473895	0.2 mg/ml in 2 ml vial	Available		Y
Haloperidol N05AD01 Palliative Not listed in Equipment Standards	Fresenius Kabi	Haloperidol injection USP	02406411	5 mg/ml in 1 ml vial	Available
	Omega Laboratories	Haloperidol injection	02366010	5 mg/ml in 1 ml vial	Available		Y
	Sandoz	Haloperidol injection USP	00808652	5 mg/ml in 1 ml ampoule	Available		Y
HYDROmorphone N05AD03 Palliative Not listed in Equipment Standards	Fresenius Kabi	HYDROmorphone Hydrochloride Injection, USP	02491680	10 mg/ml in 1 ml vial	Available	Drug Shortage Report for HYDROMORPHONE HYDROCHLORIDE INJECTION, USP Fresenius Kabi Canada regrets to advise that due to shipping delays, we will be encountering a supply interruption on our HYDROmorphone Hydrochloride Injection, USP 10 mg/mL SD Vial 1 mL effective June 7, 2024 until June 28, 2024.
	Fresenius Kabi	HYDROmorphone Hydrochloride Injection, USP	02491699	2 mg/ml in 1 ml vial	Anticipated Shortage	Estimated end 19-Jul-2024
	JAMP Pharma	HYDROmorphone Hydrochloride Injection USP	02529645	2 mg/ml in 1 ml vial	Available
	Sandoz	HYDROmorphone HP 10	02145928	10 mg/ml in 1 ml vial	Available		Y
	Sandoz	HYDROmorphone Hydrochloride Injection USP	02145901	2 mg/ml in 1 ml vial	Available		Y
	Sterimax	HYDROmorphone Hydrochloride Injection HP 10	02460610	10 mg/ml in 1 ml vial	Available		Y
	Sterimax	HYDROmorphone Hydrochloride Injection USP	02460602	2 mg/ml in 1 ml vial	Available
Hydroxocobalamin V03AB33 Chem Ex Sodium Thiosulfate 25% is appropriate substitute Not in equipment standards	Serb SA	Cyanokit	02375370	5 g powder for infusion in glass vial	Available (T3)		Y
Ibuprofen M01AE01 All units Min: 800 mg Std: 400 mg/dose	Apotex	Apo-Ibuprofen	00441643	200 mg tablet	Available	Drug Shortage Report for APO-IBUPROFEN 1000 BTL available	Y
	Apotex	Apo-Ibuprofen	00506052	400 mg tablet	Available	Drug Shortage Report for APO-IBUPROFEN 100 BTL shortage, 1000 BTL available	Y
	Apotex	Apo-Ibuprofen	02439689	200 mg tablet	Available
	GlaxoSmithKline	Advil tablets	01933558	200 mg tablet	Available
	GlaxoSmithKline / CareRx	Advil extra strength caplets (CareRx)	02244577	400 mg tablet	Available		Y
	JAMP Pharma	Ibuprofen	02257912	200 mg tablet	Available
	JAMP Pharma	Ibuprofen	02317338	400 mg tablet	Available
	McNeil Consumer Healthcare	Motrin	02186934	200 mg tablet	Available
	McNeil Consumer Healthcare	Motrin	02242658	400 mg tablet	Available
	Pharmascience	Extra Strength Ibuprofen	02314770	400 mg tablet	Available
	Pharmascience	Ibuprofen Tablets	02314754	200 mg tablet	Available
	Vita Health Products	Ibuprofen Tablets	02272849	200 mg tablet	Available
	Vita Health Products	Ibuprofen Tablets	02368072	200 mg tablet	Available
Ketamine N01AX03 ACP units Min: 1000 mg Std: n/a	Sandoz	Ketamine Hydrochloride USP	02246796	50 mg/ml in 10 ml vial	Available	Stock available at wholesalers.	Y	CMP-36120
	Sandoz	Ketamine Hydrochloride USP	02246796	50 mg/ml in 2 ml vial	Available		Y
	Searchlight Pharma	Ketalar	00224405	50 mg/ml in 10 ml vial	Available
	Searchlight Pharma	Ketalar	00224391	10 mg/ml in 20 ml vial	Available
Ketorolac M01AB15 All units Min: 2 vials/amps Std: 10 - 15 mg/dose	Atnahs Pharma	TORADOL IM	02162644	10 mg/ml in 1 ml ampoule	Available
	Fresenius Kabi	Ketorolac Tromethamine Injection, USP	02244947	30 mg/ml in 1 ml vial	Available		Y
	Juno Pharmaceuticals	Ketorolac Tromethamine Injection, USP	02443376	30 mg/ml in 1 ml vial	Available		Y
	Pfizer	Ketorolac Tromethamine Injection, USP	02390582	30 mg/ml in 1 ml vial	Shortage	Estimated end TBD
	Sandoz	Ketorolac Tromethamine Injection, USP	02239944	30 mg/ml in 1 ml vial	Discontinued	Remaining supply date 30-Sept-2025
Lidocaine injection C01BB01 ACP units if not carrying amiodarone Min: 600 mg Std: n/a	Aspen Pharmacare	Xylocard	00001937	20 mg/ml in 5 ml ampoule	Anticipated Shortage	Estimated end 30-Sep-2024	Y
	Laboratoire Aguettant	Lidocaine Hydrochloride injection	02522268	100 mg in 5 ml prefilled syringe	Available
	Pfizer	Lidocaine Hydrochloride injection USP: Ansyr	00436208	100 mg in 5 ml prefilled syringe	Shortage	Estimated end TBD On allocation	Y	CMP-35516
	Pfizer	Lidocaine Hydrochloride injection USP: LifeShield	00436208	100 mg in 5 ml prefilled syringe	Shortage	Estimated end, TBD	Y	CMP-35516
Lidocaine spray N01BB02 ACP units Min: 2 Std: 10 mg/spray	Aspen Pharmacare	Xylocaine Spray	02003767	10 mg/metered dose spray	Available
Lidocaine spray N01BB02 ACP units Min: 2 Std: 10 mg/spray	Odan Laboratories	Lidoan endotracheal non-aerosol spray	02231147	10 mg/metered dose spray	Available		Y
Methoxyflurane 99.9% N02BG09 Research Project Not in equipment standards	Endo Ventures	Penthrox	2474727	3 ml bottle and inhaler	Available
Midazolam N05CD08 ACP units Min: 20 mg Std: n/a	Fresenius Kabi	Midazolam injection	02242905	5 mg/ml x 2 ml vial	Available
	Pfizer	Midazolam injection USP	02382350	5 mg/ml x 2 ml vial	Available
	Pfizer	Midazolam injection USP	02382385	5 mg/ml x 2 ml vial	Available
	Sandoz	Midazolam injection	02240286	5 mg/ml x 2 ml vial	Available		Y
Morphine N02AA01 ACP units Min: 40 mg Std: n/a	Fresenius Kabi	Morphine Sulfate injection, USP	02482746	10 mg/ml in 1 ml vial	Available	Drug Shortage Report for MORPHINE SULFATE INJECTION, USP Fresenius Kabi Canada regrets to advise that due to production delays, we will be encountering a supply interruption on our Morphine Sulfate Injection, USP 10 mg / mL SD Vial 1 mL effective April 25, 2025, until July 18, 2025.
	JAMP Pharma	Morphine Sulfate injection	02500728	10 mg/ml in 1 ml ampoule	Available
	JAMP Pharma	Morphine Sulfate injection	02500736	15 mg/ml in 1 ml ampoule	Available
	Sandoz	Morphine Sulfate injection USP	02382997	10 mg/ml in 1 ml ampoule	Available		Y
	Sandoz	Morphine Sulfate injection USP	00392561	15 mg/ml in 1 ml ampoule	Available
	Sandoz	Morphine Sulfate injection BP	00392588	10 mg/ml in 1 ml ampoule	Available		Y
	Sterimax	Morphine Sulfate injection BP	02474980	15 mg/ml in 1 ml ampoule	Available
Naloxone V03AB15 All units Min: 12 mg Std: n/a	Hikma	Naloxone hydrochloride injection USP	02382482	0.4 mg/ml in 1 ml ampoule	Shortage	Estimated end 01-Mar-2024	Y
	Hikma	Naloxone injectable	02458578	0.4 mg/ml in 1 ml ampoule	Available
	Omega Laboratories	Injectable naloxone hydrochloride	02455935	0.4 mg/ml in 1 ml vial	Available
	Sandoz	Naloxone HCL Injection	02148706	0.4 mg/ml in 1 ml ampoule	Available
	Sandoz	Naloxone HCL Injection	02148714	1 mg/ml in 2 ml vial	Available		Y
	Sandoz	S.O.S. Naloxone hydrochloride injection	02453258	0.4 mg/ml in 1 ml ampoule	Available
Nitroglycerin C01DA02 All units Min: 2 canisters or bottles Std: 0.4 mg/dose, aerosol OR 0.3 or 0.4 mg/dose tablets	BGP Pharma	Nitrostat	00037613	0.3 mg SL tablet	Available			CMP-32011
	Juno Pharmaceuticals	Glyceryl trinitrate sublingual spray	UK PL 18190/0013	0.4 mg/metered dose spray	Unknown	UK product that may be imported until 31 Jan 2024		CMP-32011
	Mylan Pharmaceuticals	Mylan-Nitro Sublingual Spray	02243588	0.4 mg/metered dose spray	Discontinued	Discontinued 2024-05-01-The last lots and expiry dates are 0F904/30-Jun-2023 and 0G910/31-Jul-2023 - Reported in shortage ID 181369 Expiry date extension		CMP-32011
	Sandoz	Rho-Nitro Pumpspray	02238998	0.4 mg/metered dose spray	Shortage	Estimated end TBD Limited inventory available.	Y	CMP-32011
	Sanofi-Aventis	Nitrolingual Pumpspray	02231441	0.4 mg/metered dose spray	Shortage (T3)	Estimated end 30-Jun-2024		CMP-32011
Ondansetron injection A04AA01 Palliative	Auro Pharma	Auro-ondansetron injection	02491524	2 mg/ml in 2 ml vial	Available	Drug Shortage Report for AURO-ONDANSETRON INJECTION
	Auro Pharma	Auro-ondansetron injection	02491532	2 mg/ml in 2 ml vial	Available
	Auro Pharma	Ondansetron Injection BP	02461420	2 mg/ml in 2 ml ampoule	Available
	Marcan Pharmaceuticals	Ondansetron Injection USP	02503905	2 mg/ml in 2 ml vial	Available		Y
	Sandoz	Ondansetron Hydrochloride Dihydrate Injection	02274418	2 mg/ml in 2 ml ampoule	Available		Y
	Sandoz	Ondansetron Injection USP	02279428	2 mg/ml in 2 ml vial	Available
	Sterimax	Ondansetron Injection USP	02464578	2 mg/ml in 2 ml vial	Available	Drug Shortage Report for ONDANSETRON INJECTION USP Inventory remains available at McKesson	Y
Ondansetron oral A04AA01 All units Min: 8 mg Std: n/a	Accel Pharma	Accel-Ondansetron ODT	02535319	4 mg orally disintegrating tablet	Shortage	Estimated end 15-Jun-2024 Recall: https://recalls-rappels.canada.ca/en/alert-recall/accel-ondansetron-odt-4-8-mg-data-integrity-concerns-product-s-bioequivalence-data
	Athena Pharamaceutiques	Athena-ondansetron ODT	02444674	4 mg orally disintegrating tablet	Available
	Auro Pharma	Auro-ondansetron ODT	02511282	4 mg orally disintegrating tablet	Available	Drug Shortage Report for AURO-ONDANSETRON ODT	Y
	JAMP Pharma	Ondansetron ODT	02519232	4 mg orally disintegrating tablet	Available		Y
	Marcan Pharmaceuticals	Mar-Ondansetron ODT	02514966	4 mg orally disintegrating tablet	Available		Y
	Mint Pharmaceuticals	Mint-Ondansetron ODT	02487330	4 mg orally disintegrating tablet	Available		Y
	Pharmascience	PMS-Ondansetron ODT	02519445	4 mg orally disintegrating tablet	Available		Y
	Sandoz	Ondansetron ODT	02481723	4 mg orally disintegrating tablet	Available		Y
	Sandoz	Zofran ODT	02239372	4 mg orally disintegrating tablet	Available
	Takeda	Ondissolve	02389983	4 mg oral soluble film	Shortage	Estimated end 31-Oct-2025 Drug Shortage Report for ONDISSOLVE ODF
Oxytocin H01BB02 All units Min: 20 units (2 doses) Std: 10 units/ml	Fresenius Kabi	Oxytocin Injection USP	02139561	10 units/ml in 1 ml vial	Available		Y	CMP-33205
	Pfizer	Oxytocin Injection USP	00497398	10 units/ml in 1 ml ampoule	Shortage	Estimated end 30-Sept-2024		CMP-33205
Pralidoxime V03AB13 Chem Ex Not in equipment standards	Not marketed in Canada
Salbutamol inhalation solution R03AC02 All units Min: 25 mg Std: n/a	Pharmascience	PMS-Salbutamol	02208229	2.5 mg in 2.5 ml nebule	Shortage (T3)	Estimated end date 10-Mar-2025	Y
	Pharmascience	PMS-Salbutamol	02208237	5 mg in 2.5 ml nebule	Shortage (T3)	Estimated end date 03-Mar-2025	Y
	Teva	Teva-Salbutamol Sterinebs	01926934	2.5 mg in 2.5 ml nebule	Shortage (T3)	Estimated end date 10-Feb-2025	Y
	Teva	Teva-Salbutamol Sterinebs	02173360	5 mg in 2.5 ml nebule	Shortage (T3)	Estimated end date 31-Mar-2025	Y
Salbutamol MDI R03AC02 All units Min: 2 canisters Std: 100 mcg/puff, aerosol	Apotex	Apo-Salbutamol HFA	02245669	100 mcg/metered dose MDI	Available (T3)	Drug Shortage Report for APO-SALBUTAMOL HFA	Y
	GlaxoSmithKline	Ventolin HFA	02241497	100 mcg/metered dose MDI	Available	Drug Shortage Report for VENTOLIN HFA Increase in demand coupled with delay in shipment of the drug. Inventory on allocation to support demand.	Y
	Sanis Health	Salbutamol HFA	02419858	100 mcg/metered dose MDI	Available	Drug Shortage Report for SALBUTAMOL HFA
	Teva	Teva-Salbutamol HFA	02326450	100 mcg/metered dose MDI	Available (T3)	Drug Shortage Report for TEVA-SALBUTAMOL HFA Product in on allocation for duration of shortage.	Y
Sodium Bicarbonate B05XA02 ACP units Min: 2 Std: 50 mEq/50 ml (50 ml of 84 mg/ml)	Fresenius Kabi	Sodium Bicarbonate Injection, USP	02486636	50 mEq in 50 ml vial	Shortage	Estimated end 09-Dec-2025 Due to a delay in production, we will be encountering a supply interruption effective October 1, 2025, until December 9, 2025. Sterimax is an alternate supplier of this product and will be able to provide coverage during this time.	Y
	JAMP Pharma	Sodium Bicarbonate Injection USP	02516225	50 mEq in 50 ml vial	Available	Allocation
	Omega Laboratories	Sodium Bicarbonate Injection USP	02467585	50 mEq in 50 ml vial	Available		Y
	Pfizer	Sodium Bicarbonate Injection USP, ABBOJECT Syringe	00261998	50 mEq in 50 ml prefilled syringe	Available
	Pfizer	Sodium Bicarbonate Injection USP, fliptop Vial		50 mEq in 50 ml vial	Shortage	Estimated end TBD On allocation	Y
	Pfizer	Sodium Bicarbonate Injection USP, LifeShield Syringe		50 mEq in 50 ml prefilled syringe	Discontinued (18-Aug-2025)	50mL vial format remains available	Y
Sodium Chloride 0.9% (diluent) B05XA03 V07AB Not in equipment standards	BD	PosiFlush	None	10 ml prefilled syringe	unknown		Y
	Hikma / Teligent	0.9% Sodium Chloride Injection USP	02304341	10 ml ampoule	Available		Y
	Omega Laboratories	0.9% Sodium Chloride Injection USP	02150204	10 ml vial	Available
	Pfizer	Bacteriostatic Sodium Chloride Injection USP	00037818	10 ml vial	Available
	Pfizer	Sodium Chloride Injection USP	00037796	10 ml vial	Anticipated Shortage	Estimated end TBD Inventory on allocation	Y
Sodium Chloride 0.9% (IV fluid) B05XA03 ACP/PCP (AIV) units Min: 2 litres Std: ES 190 (any combination for 2 litre volume)	B. Braun Medical	0.9% Sodium Chloride Injection USP	01924303	100 ml IV bag	Available
				250 ml IV bag	Available
				500 ml IV bag	Available
				1000 ml IV bag	Available		Y
	Baxter	0.9% Sodium Chloride Injection, USP	00060208	50 ml IV bag	Shortage	Estimated end Aug-12-2024	Y
				100 ml IV bag	Available	Recall notice https://recalls-rappels.canada.ca/en/alert-recall/09-sodium-chloride-injection-usp-solution-bags-may-be-leaking-affected-lots-updated?utm_source=gc-notify&utm_medium=email&utm_content=en&utm_campaign=hc-sc-rsa-22-23&
				250 ml IV bag	Shortage	Estimated end Aug-30-2024	Y
				500 ml IV bag	Available	Recall notice https://recalls-rappels.canada.ca/en/alert-recall/09-sodium-chloride-injection-usp-solution-bags-may-be-leaking-affected-lots-updated?utm_source=gc-notify&utm_medium=email&utm_content=en&utm_campaign=hc-sc-rsa-22-23&	Y
				1,000

Sodium Chloride 0.9% (diluent)

B05XA03
V07AB

Not in equipment standards

Hikma0.9% Sodium Chloride Injection USP0230434110 ml ampouleAvailableOmega Laboratories0.9% Sodium Chloride Injection USP0215020410 ml vialAvailablePfizerBacteriostatic Sodium Chloride Injection USP0003781810 ml vialAnticipated ShortagePfizerSodium Chloride Injection USP0003779610 ml vialAnticipated Shortage

Sodium Chloride 0.9% (IV fluid)

B05XA03

ACP/PCP (AIV) units
Min: 2 litres
Std: ES 190
(any combination for 2 litre volume)

B. Braun Medical0.9% Sodium Chloride Injection USP01924303100 ml IV bagAvailable250 ml IV bagAvailable500 ml IV bagAvailable1000 ml IV bagAvailableBaxter0.9% Sodium Chloride Injection, USP0006020850 100 ml IV bagAvailable250 ml IV bagAvailable500 ml IV bagAvailable

ml IV bag

Available

Recall notice

https://recalls-rappels.canada.ca/en/alert-recall/09-sodium-chloride-injection-

injections-solution-bags-may-be-leaking-affected-lots

usp-solution-bags-may-be-leaking-affected-lots-updated?utm_source=gc-notify&utm_medium=email&utm_content=en&utm_campaign=hc-sc-rsa-22-23&

Y

Fresenius Kabi	0.9% Sodium Chloride Injection	02395150	50 ml IV bag	Available
			100 ml IV bag	Available
			250 ml IV bag	Available
			500 ml IV bag

Available

Shortage

Estimated end 19-Nov-2024

This product is on backorder.

1000 ml IV bag

Available

ICU Medical

Sodium Chloride Injection USP

00037842

50 ml IV bag

Anticipated Shortage

Estimated end unknown

Available


100 ml IV bag	Available
250 ml IV bag	Available	Drug Shortage Report for SODIUM CHLORIDE INJECTION USP
500 ml IV bag	Available	Drug Shortage Report for SODIUM CHLORIDE INJECTION USP	Y
Sodium Thiosulfate 25% V03AB06 Chem Ex Hydroxocobalamin is appropriate substitute Not in equipment standards	Hope Pharmaceuticals	Sodium Thiosulfate injection USP	02428393	250 mg/ml in 50 ml vial	Available
	Pfizer	Sodium Thiosulfate injection USP	02137186	250 mg/ml in 10 ml vial	Available
	Seaford Pharmaceuticals	Seacalpyx	02386666	250 mg/ml in 100 ml vial	Available
Tranexamic Acid B02AA02 Expected drug	Auro Pharma	Tranexamic Acid injection	02466015	100 mg/ml in 10 ml ampoule	Available
	JAMP Pharma	Tranexamic Acid injection	02497328	100 mg/ml in 10 ml vial	Available
	Omega Laboratories	Tranexamic Acid injection	02392763	100 mg/ml in 10 ml vial

Shortage

Available
Pfizer	Cyklokapron	02064413	100 mg/ml in 10 ml ampoule

Shortage

Estimated end 09-Feb-2026

Available


Sandoz	Tranexamic Acid injection BP	02246365	100 mg/ml in 10 ml vial	Available
Searchlight Pharma	ERFA-Tranexamic	02457431	100 mg/ml in 10 ml vial	Shortage	Estimated end, TBD
Water for Injection (flush/diluent) V07AB Not in equipment standards	Hikma	Sterile Water for Injection USP	02299186	10 ml ampoule	Available
	Hikma	Sterile Water for Injection USP	02299186	10 ml vial	Available
	Omega Laboratories	Sterile Water for Injection USP	00402257	10 ml vial	Available
	Pfizer	Sterile Water for Injection USP	02142546	10 ml vial	Anticipated Shortage
Xylometazoline 0.1% R01AA07 Optional Min: 2 bottles Std: n/a

GlaxoSmithKlineOtrivin Medicated Cold & Allergy Relief

CRLS

Decongestant Nasal Spray

02452812

00653330

0.1% spray, nasal spray

Available

GlaxoSmithKlineOtrivin Medicated Cold & Allergy Relief


CRLS	Decongestant Nasal Spray with moisturizers

02208903

02452863	0.1% spray, nasal spray	Available
GlaxoSmithKline	Otrivin Medicated

Complete Nasal Care02331403

Cold & Allergy Relief

00653330

0.1% spray, nasal spray

Available

CRLSDecongestant Nasal Spray

	Y
GlaxoSmithKline	Otrivin Medicated Cold & Allergy Relief with moisturizers	02208903

02452812

0.1% spray, nasal spray

Available

CRLSDecongestant Nasal Spray with moisturizers

	Y
GlaxoSmithKline	Otrivin Medicated Complete Nasal Care	02331403

02452863

0.1% spray, nasal spray

Available

The Drug Availability Database was developed and compiled by James Bowen, with the RPPEO, 2023.

The data for the Drug Availability Database is publicly available, however the collection and layout represents intellectual labour of RPPEO staff, where this is used please credit the RPPEO and James Bowen

Page tree

Page History

Versions Compared

Old Version 18

New Version Current

Key

Last Update 16 Aug 2023 03 Oct 2025

Welcome to RPPEO's Drug Availability Database, a one stop site for information on drug availability for Ontario Paramedicine.

Using the Drug Availability Database

Drug Status Legend

Drug Availability Database

Acetaminophen

Amiodarone

Antibiotic eye drops

Antibiotic ointment

ASA (Acetylsalicylic acid)

Atropine

Buprenorphine/Naloxone

Calcium Gluconate

Dexamethasone

Dextrose

Diazepam

DimenhyDRINATE

DiphenhydrAMINE(injection)

DiphenhydrAMINE(oral)

Dopamine

EPINEPHrine 1:1,000 (1 mg/ml)

EPINEPHrine 1:10,000 (0.1 mg/ml)

Fentanyl

Glucagon

Glucose (oral)

Glycopyrrolate

Haloperidol

HYDROmorphone

Hydroxocobalamin

Ibuprofen

Ketamine

Ketorolac

Lidocaine injection

Lidocaine spray

Methoxyflurane 99.9%

Midazolam

Morphine

Naloxone

Nitroglycerin

Ondansetron injection

Ondansetron oral

Oxytocin

Pralidoxime

Salbutamol inhalation solution

Salbutamol MDI

Sodium Bicarbonate

Adenosine

Amiodarone

Antibiotic eye drops

Antibiotic ointment

ASA (Acetylsalicylic acid)

Atropine

Buprenorphine/Naloxone

Calcium Gluconate

Dexamethasone

Dextrose

Diazepam

DimenhyDRINATE

DiphenhydrAMINE(injection)

DiphenhydrAMINE(oral)

Dopamine

EPINEPHrine 1:1,000 (1 mg/ml)

EPINEPHrine 1:10,000 (0.1 mg/ml)

Fentanyl

Glucagon

Glucose (oral)

Glycopyrrolate

Haloperidol

HYDROmorphone

Hydroxocobalamin

Ibuprofen

Ketamine

Ketorolac

Lidocaine injection

DiphenhydrAMINE
(injection)

DiphenhydrAMINE
(oral)

DiphenhydrAMINE
(injection)

DiphenhydrAMINE
(oral)